The primary goal of this report is to promote patient safety while providing risk management and practice guidance to HBVinfected health-care providers and students, particularly those performing exposure-prone procedures such as certain types of surgery. Because percutaneous injuries sustained by health-care personnel during certain surgical, obstetrical, and dental procedures provide a potential route of HBV transmission to patients as well as providers, this report emphasizes prevention of operator injuries and blood exposures during exposure-prone surgical, obstetrical, and dental procedures.
References:
In the MMWR Recommendations and Reports “Updated CDC Recommendations for the Management of Hepatitis B Virus–Infected Health-Care Providers and Students,” an error occurred on page 4 in the second sentence of the section headed “Treatments for Chronic Hepatitis B Infection.” The sentence should read, “Currently, seven therapeutic agents are approved by the Food and Drug Administration for the treatment of chronic hepatitis B, including two formulations of interferon (interferon alpha and pegylated interferon) and five nucleoside or nucleotide analogs (lamuvidine, telbivudine, adefovir, entecavir, and tenofovir).”
Comentarios